Solid Tumors

Showing NaN - NaN of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Solid Tumors Trial in Worldwide (INCB0123667)

Recruiting
  • Solid Tumors
  • Duarte, California
  • +34 more
Dec 12, 2022

Solid Tumors Trial in Kashiwa, Suita, Chuo Ku (S-531011, Pembrolizumab)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +5 more
Oct 6, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Solid Tumors Trial in Worldwide (Pembrolizumab, Standard of Care (SOC))

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +374 more
Aug 22, 2022

Solid Tumors Trial in United States (EZN-2208)

Terminated
  • Solid Tumors
  • Aurora, Colorado
  • +3 more
Jan 29, 2022

Solid Tumors Trial in Worldwide (Tislelizumab, Pamiparib)

Completed
  • Solid Tumors
  • Scottsdale, Arizona
  • +28 more
Oct 27, 2021

Solid Tumors Trial in Chicago, Philadelphia, San Antonio (CEP-37440)

Completed
  • Solid Tumors
  • Chicago, Illinois
  • +2 more
Nov 5, 2021

Solid Tumors, Lymphoma Trial in Boston, Philadelphia (PM00104)

Terminated
  • Solid Tumors
  • Lymphoma
  • Boston, Massachusetts
  • +1 more
Jul 7, 2021

Solid Tumors Trial in Worldwide (axitinib, crizotinib)

Active, not recruiting
  • Solid Tumors
  • Orange, California
  • +33 more
Jan 30, 2021

Solid Tumors Trial in Worldwide (BMS-986156, Nivolumab)

Completed
  • Solid Tumors
  • Birmingham, Alabama
  • +26 more
Dec 15, 2020

Solid Tumors Trial in Worldwide (Tivozanib + paclitaxel, Tivozanib + temsirolimus, Tivozanib)

Terminated
  • Solid Tumors
  • Tivozanib + paclitaxel
  • +5 more
  • Scottsdale, Arizona
  • +48 more
Aug 17, 2020

Solid Tumors Trial in United States (MLN4924, Paclitaxel, Gemcitabine)

Completed
  • Solid Tumors
  • Atlanta, Georgia
  • +5 more
Jun 5, 2020

Solid Tumors Trial in Worldwide (Atezolizumab, Selicrelumab)

Completed
  • Solid Tumors
  • Philadelphia, Pennsylvania
  • +10 more
Dec 11, 2019

Solid Tumors Trial in Baltimore, Philadelphia (ACE 011)

Terminated
  • Solid Tumors
  • ACE 011
  • Baltimore, Maryland
  • +2 more
Oct 30, 2019

Solid Tumors, Pancreatic Cancer Trial in United States (itacitinib, Gemcitabine, nab-paclitaxel)

Completed
  • Solid Tumors
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +7 more
Jul 16, 2019

Solid Tumors Trial in United States (RXDX-105)

Completed
  • Solid Tumors
  • Duarte, California
  • +13 more
Apr 24, 2019

Solid Tumors Trial in United States (Ramucirumab (IMC-1121B), Irinotecan, Folinic acid)

Completed
  • Solid Tumors
  • Ramucirumab (IMC-1121B)
  • +3 more
  • Detroit, Michigan
  • +4 more
Feb 3, 2019

Pediatrics, Solid Tumors Trial in United States (Eribulin Mesylate)

Completed
  • Pediatrics
  • Solid Tumors
  • Eribulin Mesylate
  • Birmingham, Alabama
  • +17 more
Jan 2, 2019